rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2000-11-9
|
pubmed:abstractText |
The aim of this study was to compare FDG PET with a new monoclonal antibody-based imaging agent that comprises an anti-carcinoembryonic antigen (CEA) monoclonal antibody Fab' fragment directly labeled with 99mTc.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1657-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11037995-Antibodies, Monoclonal,
pubmed-meshheading:11037995-Bone Neoplasms,
pubmed-meshheading:11037995-Colorectal Neoplasms,
pubmed-meshheading:11037995-Female,
pubmed-meshheading:11037995-Fluorodeoxyglucose F18,
pubmed-meshheading:11037995-Humans,
pubmed-meshheading:11037995-Liver Neoplasms,
pubmed-meshheading:11037995-Lung Neoplasms,
pubmed-meshheading:11037995-Lymphatic Metastasis,
pubmed-meshheading:11037995-Male,
pubmed-meshheading:11037995-Middle Aged,
pubmed-meshheading:11037995-Neoplasm Recurrence, Local,
pubmed-meshheading:11037995-Organotechnetium Compounds,
pubmed-meshheading:11037995-Predictive Value of Tests,
pubmed-meshheading:11037995-Radioimmunodetection,
pubmed-meshheading:11037995-Radiopharmaceuticals,
pubmed-meshheading:11037995-Sensitivity and Specificity,
pubmed-meshheading:11037995-Tomography, Emission-Computed,
pubmed-meshheading:11037995-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
2000
|
pubmed:articleTitle |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Bonn, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|